|
Brendan O�Leary, Ph.D. is an integral member of the Prism VentureWorks life sciences team, where he focuses on companies in the medical device, pharmaceutical and diagnostic sectors. Dr. O�Leary currently sits on the board of several life sciences companies including Locus Pharmaceuticals, Proteon Therapeutics, ROX Medical, and Trius Therapeutix. He was previously a director at BioRexis Pharmaceuticals (acquired by Pfizer). Prior to joining Prism Dr. O�Leary held senior operating positions at several biotechnology and medical technology companies including Meso Scale Discovery, a high throughput discovery start-up, and IGEN International, a leading medical diagnostics company that was acquired by Roche. Dr. O�Leary received his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and holds a B.A. in Chemistry and Economics from Middlebury College. | 